These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7818116)

  • 1. Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain.
    Leow KP; Cramond T; Smith MT
    Anesth Analg; 1995 Feb; 80(2):296-302. PubMed ID: 7818116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer.
    Leow KP; Smith MT; Williams B; Cramond T
    Clin Pharmacol Ther; 1992 Nov; 52(5):487-95. PubMed ID: 1424423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration.
    Leow KP; Smith MT; Watt JA; Williams BE; Cramond T
    Ther Drug Monit; 1992 Dec; 14(6):479-84. PubMed ID: 1485370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children.
    Kokki H; Rasanen I; Reinikainen M; Suhonen P; Vanamo K; Ojanperä I
    Clin Pharmacokinet; 2004; 43(9):613-22. PubMed ID: 15217304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone.
    Takala A; Kaasalainen V; Seppälä T; Kalso E; Olkkola KT
    Acta Anaesthesiol Scand; 1997 Feb; 41(2):309-12. PubMed ID: 9062618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
    Chan S; Edwards SR; Wyse BD; Smith MT
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oxycodone after intravenous and subcutaneous administration in Japanese patients with cancer pain.
    Kokubun H; Yoshimoto T; Hojo M; Fukumura K; Matoba M
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):338-50. PubMed ID: 25359452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children.
    Olkkola KT; Hamunen K; Seppälä T; Maunuksela EL
    Br J Clin Pharmacol; 1994 Jul; 38(1):71-6. PubMed ID: 7605420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
    Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
    Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain.
    Kokubun H; Fukawa M; Matoba M; Hoka S; Yamada Y; Yago K
    Biol Pharm Bull; 2007 Nov; 30(11):2173-7. PubMed ID: 17978495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of controlled-release oxycodone in patients with cancer pain].
    Nakamura K; Kokubun H; Komatsu T; Matoba M; Hoka S; Yago K
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1449-53. PubMed ID: 17876144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of oxycodone in patients with cancer-related pain.
    Komatsu T; Kokubun H; Suzuki A; Takayanagi R; Yamada Y; Matoba M; Yago K
    J Pain Palliat Care Pharmacother; 2012 Sep; 26(3):220-5. PubMed ID: 22973910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers.
    Smith K; Hopp M; Mundin G; Leyendecker P; Bailey P; Grothe B; Uhl R; Reimer K
    Clin Ther; 2008 Nov; 30(11):2051-68. PubMed ID: 19108793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy.
    Kokki M; Välitalo P; Rasanen I; Aaltomaa S; Ojanperä I; Eskelinen M; Kokki H
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1357-63. PubMed ID: 22451244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays.
    Kalso E; Vainio A; Mattila MJ; Rosenberg PH; Seppälä T
    Pharmacol Toxicol; 1990 Oct; 67(4):322-8. PubMed ID: 2077525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?
    Charles B; Hardy J; Anderson H; Tapuni A; George R; Norris R
    Support Care Cancer; 2014 Feb; 22(2):325-30. PubMed ID: 24077699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR; Moore J; Gray RO; Skinner L; Biros MH
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous oxycodone for pain relief in the first stage of labour--maternal pharmacokinetics and neonatal exposure.
    Kokki M; Franco MG; Raatikainen K; Välitalo P; Sankilampi U; Heinonen S; Neuvonen PJ; Kokki H
    Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):182-8. PubMed ID: 22448718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.